Zacks Investment Research downgraded shares of Leidos (NYSE:LDOS) from a buy rating to a hold rating in a report published on Tuesday.

According to Zacks, “Leidos Holdings, Inc. (Leidos) is a holding company whose direct 100%-owned subsidiaries and principal operating companies are Leidos, Inc. and Leidos Innovations Corporation. Leidos is a global science and technology company that provides technology and engineering services and solutions in the defense, intelligence, civil and health markets. Their domestic customers include agencies of the U.S. Department of Defense, the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Health and Human Services, other U.S. Government civil agencies and state and local government agencies. Their international customers include foreign governments and their agencies, primarily located in the United Kingdom, the Middle East and Australia. “

How to Become a New Pot Stock Millionaire

A number of other equities research analysts also recently weighed in on the stock. Citigroup upped their price target on shares of Leidos from $71.00 to $75.00 and gave the company a buy rating in a report on Monday, February 26th. Credit Suisse Group reaffirmed an outperform rating and set a $81.00 price objective (up from $79.00) on shares of Leidos in a research note on Friday, February 23rd. Jefferies Group upped their price objective on shares of Leidos from $75.00 to $80.00 and gave the company a buy rating in a research note on Friday, February 23rd. ValuEngine raised shares of Leidos from a hold rating to a buy rating in a research note on Friday, February 2nd. Finally, Cowen reaffirmed a buy rating and set a $72.00 price objective on shares of Leidos in a research note on Tuesday, December 19th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of $71.80.

Shares of Leidos (LDOS) opened at $69.30 on Tuesday. Leidos has a 1-year low of $49.84 and a 1-year high of $70.11. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.21 and a quick ratio of 1.01. The firm has a market cap of $10,502.19, a PE ratio of 18.54, a price-to-earnings-growth ratio of 1.66 and a beta of 1.71.

Leidos (NYSE:LDOS) last issued its quarterly earnings results on Thursday, February 22nd. The aerospace company reported $0.87 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.83 by $0.04. Leidos had a net margin of 3.60% and a return on equity of 17.47%. The company had revenue of $2.52 billion during the quarter, compared to the consensus estimate of $2.57 billion. During the same period in the prior year, the company earned $0.75 EPS. Leidos’s revenue was down 2.3% on a year-over-year basis. equities research analysts anticipate that Leidos will post 4.41 earnings per share for the current fiscal year.

Leidos announced that its board has approved a share repurchase plan on Thursday, February 22nd that permits the company to buyback 20,000,000 shares. This buyback authorization permits the aerospace company to purchase shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its shares are undervalued.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 15th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date of this dividend is Wednesday, March 14th. Leidos’s dividend payout ratio is presently 53.78%.

A hedge fund recently raised its stake in Leidos stock. Cambridge Investment Research Advisors Inc. grew its holdings in Leidos Holdings, Inc. (NYSE:LDOS) by 89.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,566 shares of the aerospace company’s stock after purchasing an additional 7,352 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Leidos were worth $1,005,000 as of its most recent SEC filing. 73.08% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Leidos (LDOS) Cut to Hold at Zacks Investment Research” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.dailypolitical.com/2018/03/14/leidos-ldos-cut-to-hold-at-zacks-investment-research.html.

About Leidos

Leidos Holdings, Inc (Leidos) is a science and technology solutions company focused on delivering solutions primarily in the areas of national security, health and engineering. The Company is a holding company whose direct 100%-owned subsidiary is Leidos, Inc, which delivers science and technology solutions in the areas of national security, health and engineering to agencies of the United States Department of Defense (DoD), the intelligence community, the United States Department of Homeland Security, and other United States Government civil agencies, state and local government agencies, foreign governments and customers across a variety of commercial markets.

Get a free copy of the Zacks research report on Leidos (LDOS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Leidos (NYSE:LDOS)

Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.